Follow
MICHAEL TOSS
MICHAEL TOSS
Assistant Lecturer, Department of Pathology, South Egypt Cancer Institute, Assiut University
Verified email at aun.edu.eg - Homepage
Title
Cited by
Cited by
Year
Determining breast cancer biomarker status and associated morphological features using deep learning
P Gamble, R Jaroensri, H Wang, F Tan, M Moran, T Brown, ...
Communications medicine 1 (1), 14, 2021
942021
Current and future applications of artificial intelligence in pathology: a clinical perspective
EA Rakha, M Toss, S Shiino, P Gamble, R Jaroensri, CH Mermel, ...
Journal of clinical pathology 74 (7), 409-414, 2021
932021
Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance
M Althobiti, MA Aleskandarany, C Joseph, M Toss, N Mongan, ...
Histopathology 73 (6), 887-896, 2018
852018
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
MS Toss, I Miligy, A Al-Kawaz, M Alsleem, H Khout, PC Rida, R Aneja, ...
Modern Pathology 31 (8), 1226-1236, 2018
792018
SlideGraph+: Whole slide image level graphs to predict HER2 status in breast cancer
W Lu, M Toss, M Dawood, E Rakha, N Rajpoot, F Minhas
Medical Image Analysis 80, 102486, 2022
712022
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
A Katayama, IM Miligy, S Shiino, MS Toss, K Eldib, S Kurozumi, CM Quinn, ...
Modern Pathology 34 (7), 1271-1281, 2021
622021
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
C Joseph, M Arshad, S Kurozomi, M Althobiti, IM Miligy, S Al-Izzi, MS Toss, ...
Breast Cancer Research and Treatment 174, 387-399, 2019
612019
Breast cancer histologic grading using digital microscopy: concordance and outcome association
EA Rakha, M Aleskandarani, MS Toss, AR Green, G Ball, IO Ellis, ...
Journal of clinical pathology 71 (8), 680-686, 2018
542018
A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
S Klimov, IM Miligy, A Gertych, Y Jiang, MS Toss, P Rida, IO Ellis, A Green, ...
Breast Cancer Research 21, 1-19, 2019
492019
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts
M Alsaleem, MS Toss, C Joseph, M Aleskandarany, S Kurozumi, ...
Modern Pathology 32 (7), 967-976, 2019
482019
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy
LH Alfarsi, RE Ansari, ML Craze, MS Toss, B Masisi, IO Ellis, EA Rakha, ...
Breast cancer research and treatment 178, 535-544, 2019
442019
Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
MS Toss, IM Miligy, KL Gorringe, A AlKawaz, H Khout, IO Ellis, AR Green, ...
British journal of cancer 119 (12), 1518-1526, 2018
412018
Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations
N Wahab, IM Miligy, K Dodd, H Sahota, M Toss, W Lu, M Jahanifar, ...
The Journal of Pathology: Clinical Research 8 (2), 116-128, 2022
382022
Molecular complexity of lymphovascular invasion: the role of cell migration in breast cancer as a prototype
YA Kariri, MA Aleskandarany, C Joseph, S Kurozumi, OJ Mohammed, ...
Pathobiology 87 (4), 218-231, 2020
362020
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
MS Toss, A Abidi, D Lesche, C Joseph, S Mahale, H Saunders, T Kader, ...
British journal of cancer 122 (10), 1496-1506, 2020
362020
Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention
R Ali, A Al-Kawaz, MS Toss, AR Green, IM Miligy, KA Mesquita, ...
Cancer Research 78 (24), 6818-6827, 2018
362018
The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer
YA Kariri, M Alsaleem, C Joseph, S Alsaeed, A Aljohani, S Shiino, ...
Breast Cancer Research and Treatment 185, 293-305, 2021
352021
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ
M Toss, I Miligy, K Gorringe, K Mittal, R Aneja, I Ellis, A Green, E Rakha
Journal of Clinical Pathology 73 (2), 76-82, 2020
352020
The prognostic significance of ALDH1A1 expression in early invasive breast cancer
M Althobiti, R El Ansari, M Aleskandarany, C Joseph, MS Toss, AR Green, ...
Histopathology 77 (3), 437-448, 2020
342020
A novel prognostic two-gene signature for triple negative breast cancer
MA Alsaleem, G Ball, MS Toss, S Raafat, M Aleskandarany, C Joseph, ...
Modern Pathology 33 (11), 2208-2220, 2020
332020
The system can't perform the operation now. Try again later.
Articles 1–20